| Ms Brenna J Rock, MS CCC-SLP | |
|
1308 Waukegan Rd, Suite 103, Glenview, IL 60025-3070 | |
| (877) 486-4140 | |
| Not Available |
| Full Name | Ms Brenna J Rock |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1308 Waukegan Rd, Glenview, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043575061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 242002266 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Brenna J Rock, MS CCC-SLP 1632 Redpoll Ct, Naperville, IL 60565-2319 Ph: (815) 440-4719 | Ms Brenna J Rock, MS CCC-SLP 1308 Waukegan Rd, Suite 103, Glenview, IL 60025-3070 Ph: (877) 486-4140 |
News Archive
DySIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Health and Clinical Excellence (‘NICE') has today published positive diagnostics guidance recommending its DySIS cervical cancer screening product to be considered in procurement plans.
A new disposable device based on advances in microfluidics may help identify advanced breast cancer patients who are candidates for therapy with the drug trastuzumab (Herceptin). The device is described in the American Institute of Physics' journal Biomicrofluidics.
At more than 25 hospitals across the U.S., health care professionals have embraced a public health approach to their work-taking action to prevent violent injuries, not just treat them. In programs known as hospital-based violence intervention programs (HVIPs), teams of medical professionals, social workers and researchers step in at a critical moment in a patient's life-the period following a violent injury such as a gunshot or stab wound-with case management, counseling and other services that help these victims break free from the cycle of violence.
Researchers at the University of Vermont Cardiovascular Research Institute, Colchester, Vermont have found that increased expression in the heart of plasminogen activator inhibitor type-1 (PAI-1) is profibrotic.
Celldex Therapeutics, Inc. today announced that it has launched a pivotal, randomized, double-blind, controlled Phase 3 trial of rindopepimut in patients with surgically resected epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, the "ACT IV Study."
› Verified 3 days ago
Ms. Kelly Watson Laughlin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2591 Compass Rd, Suite 100, Glenview, IL 60026 Phone: 847-729-6220 Fax: 847-729-1116 | |
Miss Meghan Mcmahon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Mrs. Karla Rae Faems, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Allison M Raino, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1308 Waukegan Road, Suite 103, Glenview, IL 60025 Phone: 877-486-4140 | |
Miss Suzanne Michele Stroemer, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Janice Kim, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Waukegan Rd Ste 212, Glenview, IL 60025 Phone: 404-917-4969 | |
Ashley Redwine, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Compass Rd, Glenview, IL 60026 Phone: 877-787-3430 |